Xcerra Corporation (XCRA) Stocktalk | Seeking Alpha Read the latest StockTalks, investment ideas, and community discussion on Xcerra Corporation (XCRA). XCRA News: Earnings, Analyst Moves, and More Filter XCRA News Items All News Types Featured Stories Downgrade Earnings Guidance Down Guidance Up M&A PT Lowered PT Raised Rating Reiterated (Bullish) …
Rediff MyPage Refind Renren Sina Weibo SiteJot Skype Slashdot SMS StockTwits Svejo Symbaloo Bookmarks Threema Trello Tuenti Twiddla TypePad Post
XCRA: NA - Price & EPS Surprise - Zacks.com XCRA: NA price and EPS surprise. Get the latest price and EPS surprise information from Zacks Investment Research. Xcerra Corp. XCRA 14.75 0.48 (3.36%). NASDAQ Updated Oct 1, 2018 1:05 PM
Sierra Oncology Inc. SRRA 14.26 0.23 (1.64%). NASDAQ Updated Jun 8, 2020 7:59 PM
Nov 10, 2018 Fintel - Financial Intelligence Fintel® provides advanced research tools for data-driven investors Fintel currently tracks over 9500 funds and over 63,000 securities traded worldwide. Information includes fund holdings, fund sentiment, financial data, and regulatory filings (including SEC, LSE, ASX, and SGX). NA (XCRA) Cash From Operations (Quarterly) - Zacks.com
View %COMPANY_NAME% XCRA investment & stock information. Get the latest %COMPANY_NAME% XCRA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
- Stock quote for - MSN Money
Xcerra Corporation (XCRA) Company Bio. Xcerra Corporation provides test and handling capital equipment, interface products, and test fixtures and related services to the semiconductor and electronics manufacturing industries worldwide. The company was founded in 1976 and is based in Norwood, Massachusetts.
Xcerra Corp - Company Profile and News - Bloomberg Markets Company profile page for Xcerra Corp including stock price, company news, press releases, executives, board members, and contact information XCRA | CRH PLC ADR Quarterly Cash Flow Statement | MarketWatch Jun 06, 2020 NA (XCRA) Price - Zacks.com Conversely, if more people wanted to sell a stock than buy it, there would be greater supply than demand, and the price would fall. XCRA 14.27 +0.28(2.00%) Will XCRA be a Portfolio Killer in February?